英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:


请选择你想看的字典辞典:
单词字典翻译
mokarran查看 mokarran 在百度字典中的解释百度英翻中〔查看〕
mokarran查看 mokarran 在Google字典中的解释Google英翻中〔查看〕
mokarran查看 mokarran 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Hormone Therapy for Metastatic Breast Cancer - Susan G. Komen®
    The hormone therapy drugs elacestrant (Orserdu) and imlunestrant (Inluriyo) may be used to treat hormone receptor-positive, HER2-negative metastatic breast cancers that have an ESR1 tumor gene mutation in women that have been treated with hormone therapy in the metastatic setting
  • Drugs Approved for Breast Cancer - NCI
    This page lists cancer drugs approved by the Food and Drug Administration (FDA) for breast cancer The list includes generic names, brand names, and common drug combinations, which are shown in capital letters
  • Ibrance Access Guide for Patients Managing Breast Cancer
    Ibrance is the brand name for palbociclib, a targeted cancer medicine in the CDK4 6 inhibitor class It is commonly discussed as part of treatment plans for certain hormone receptor-positive, HER2-negative breast cancers It is often paired with hormone-blocking treatment rather than used alone The exact role depends on the cancer setting, prior treatment history, and the oncology team’s
  • Navigating Post-Progression Therapy in HR-Positive Metastatic Breast . . .
    As CDK4 6 inhibitors have become the foundational first-line therapy for hormone receptor–positive metastatic breast cancer, oncology pharmacists are increasingly tasked with guiding patients and providers through a rapidly expanding and complex post-progression landscape From the rise of ESR1-directed therapies and PI3K AKT mTOR pathway inhibitors to the growing role of antibody–drug
  • Breast Cancer Medications
    Here's a list of the approved drugs to treat breast cancer Click on any of the medications for more info on indications, dosing and side effects
  • Breast Cancer Medications - Prices for Brand and Generic Breast Cancer . . .
    Find the most popular and affordable Breast Cancer medication Save with or without insurance on brand and generic alternatives used to treat Breast Cancer
  • Pfizer Announces Positive Topline Phase 2 Results for Next-Generation . . .
    It was conceptualized and discovered at Pfizer and is being developed for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2-negative (HER2-) breast cancer
  • FDA approves fam-trastuzumab deruxtecan-nxki for breast cancer
    On January 27, 2025, the FDA approved fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc ) for unresectable or metastatic hormone receptor (HR)-positive, HER2-low (IHC 1+ or IHC
  • Breast Cancer Drugs
    Which breast cancer drugs are approved by the F D A ? Find all available therapies and drugs currently approved for breast cancer treatment
  • Imlunestrant (Inluriyo) for Breast Cancer: Side Effects, Cost, More
    If you were diagnosed with estrogen receptor-positive, HER2-negative advanced stage or metastatic breast cancer with an ESR1 mutation that grew during or after being treated with hormonal therapy, your doctor may prescribe imlunestrant (brand name: Inluriyo)





中文字典-英文字典  2005-2009